TickerFacts.

Polyrizon Ltd. (PLRZ): Capital Expenditures

Annual figures by period end, from SEC filings.

$7.0K
Year ended 2025-12-31
+32.6%
3-year compound annual growth
2022-12-31: $3.0K2025-12-31: $7.0K$7.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$7.0Kn/a2026-03-25, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$3.0Kn/a2025-03-11, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Polyrizon Ltd. (PLRZ)2025-12-31$7.0Kn/a
Femasys Inc (FEMY)2025-12-31$525.0K-31.1%
PolyPid Ltd. (PYPD)2025-12-31$210.0K+176.3%
INVO Fertility, Inc. (IVF)2025-12-31$43.4K-76.4%
Co-Diagnostics, Inc. (CODX)2025-12-31$700.0K-6.5%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$2.34M+312.1%
Cerenome, Inc. (CNSY)2025-12-31$67.0K-54.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%
Catheter Precision, Inc. (VTAK)2025-12-31$17.0K-74.6%

Compare PLRZ, FEMY, PYPD, IVF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗